跳至主要内容
临床试验/JPRN-UMIN000021642
JPRN-UMIN000021642已完成未知

How to prevent vascular infarction due to anti-VEGF treatment for DME - Vascular infarction due to anti-VEGF treatment for DME

Department of Ophthalmology,Mie University, School of Medicine0 个研究点目标入组 25 人开始时间: 2016年3月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Received PC treatment within 3 months. 2)Ischemic maculopathy. 3)Vitreo-macular traction syndrome. 4)Active diabetic retinopathy. 5)Any history of glaucoma. 6)Any history of optic neuropathy, 7)Any history of vitrectomy, 8)Vitreal or sub-tenon injections within 3 months before treatment. 10) Cataract surgery within 6 months before treatment.

研究者

发起方
Department of Ophthalmology,Mie University, School of Medicine

相似试验

已完成
不适用
A randomized control trial on vasovagal reaction prevention strategies in whole blood donors
CTRI/2021/01/030249All India Institute of Medical Sciences4,458
已完成
不适用
Improving the prevention of vascular events after stroke or transient ischemic attackStroke
ISRCTN63816609Royal Devon and Exeter Foundation Trust (UK)30
已完成
不适用
Prevention of portal vein thrombosis with anticoagulant therapy in patients with hepatic cirrhosisAdvanced stage cirrhosisDigestive SystemOther and unspecified cirrhosis of liver
ISRCTN32383354niversity Hospital of Modena (Azienda Ospedaliero-Universitaria di Modena) (Italy)66
进行中(未招募)
不适用
ANTIPLATELET TREATMENT FOR PREVENTION OF VASCULAR OUTCOMES IN PAD PATIENTS UNDERGOING PERIPHERAL REVASCULARIZATION.Will be enrolled in the study patients suffering from intermittent claudication in whom resulted ineffective both pharmacological and workout therapy- Will be considered eligible patients aged 40-80 inclusive, with an ankle-brachial index (ABI) <0.9 or > 1.3 at basal condition and diametrical arterial stenosis equal or superior to 50% vessel lumen, undergoing peripheral revascularization procedures.MedDRA version: 14.1Level: LLTClassification code 10003209Term: ArteriopathySystem Organ Class: 10047065 - Vascular disorders
EUCTR2012-000997-53-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
进行中(未招募)
不适用
Prevention of portal vein Thrombosis with anticoagulant therapy in patients with hepatic cirrhosis (Child B and C) - NDPazienti ambulatoriali e ospedalizzati affetti da cirrosi a eziologia virale o non, in classe B o C di Child, e assenza di trombosi portale o spleno-mesentericaMedDRA version: 6.1Level: PTClassification code 10019641
EUCTR2007-007890-22-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
How to prevent vascular infarction due to anti-VEGF... | 临床试验